As a term, there’s nothing special about nanotechnology anymore. People have gotten used to small devices and AI in their daily lives. Technology has progressed a great deal and these tiny devices’ potential applications with it.
According to experts, it’s only a matter of time before nanobots begin coursing through our bloodstream. IFL Science reports that doctors are already testing DNA robots in the human body to detect and eliminate cancer cells. These programmed DNA strands are capable of moving around and locating cancer cells. If human trials are successful, nanobots could prove quite beneficial to cancer and other cell research.
Cancer detection and elimination is one thing, but it’s not the only reason minute nanobots are big players in medical future. Researchers believe they could soon deliver drugs to patients and be highly accurate in the process. This would make it possible to administer micro dosages if harmful side effects need to be prevented.
Researchers also believe that nanobots could be utilized to solve dietary issues, reduce plaque in veins, and many other medical uses. Going beyond simple medicine, nanotechnology in surgery could prove pivotal in yielding positive outcomes. It would also help bring about greater connectivity.
In theory, nanotech could be used to monitor our body for illnesses and symptoms of them constantly, transferring this information to a cloud for careful medical monitoring. This cloud could be helpful for a series of reasons and it would basically turn pesky conditions like the common cold into easily stoppable problems.
The idea that nanotech could one day send our thoughts to the cloud is probably the least believable out of them all, but it’s still possible. Of course, this would be nothing short of a feat, requiring great leaps in both neuroscience and nano-robotics. While it is definitely possible, this functionality is farther ahead in the future.
Based on all of these facts and beliefs, the real challenges are still facing researchers. Further development is needed before we can start using nanotech this way. We also need to consider what sort of an effect nanotech will have on the employment of surgeons and their daily work and on the global drug market.
Researchers conclude that injecting nanobots into patients’ bloodstream will become a common medical practice in the next decade. Cancer and a host of other terminal illnesses will be cured, making nanobots an indispensable survival tool.